<DOC>
	<DOCNO>NCT02373202</DOCNO>
	<brief_summary>Primary Objective : To document long-term safety sarilumab add non-methotrexate ( non-MTX ) disease-modifying antirheumatic drug ( DMARDs ) monotherapy . Secondary Objective : To document long term efficacy sarilumab add non-MTX DMARDs monotherapy .</brief_summary>
	<brief_title>A Study Assessing Safety Efficacy Sarilumab Added Non-MTX DMARDs Monotherapy Japanese Patients With Active Rheumatoid Arthritis ( SARIL-RA-HARUKA )</brief_title>
	<detailed_description>Total study duration 62 week : Up 4-week screening period , 52-week treatment period , 6-week post-treatment follow-up period .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Leflunomide</mesh_term>
	<mesh_term>Bucillamine</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<mesh_term>Sulfasalazine</mesh_term>
	<criteria>Inclusion criterion : Diagnosis rheumatoid arthritis ( RA ) , accord American College Rheumatology/The European League Against Rheumatism ( ACR/EULAR ) 2010 Rheumatoid Arthritis Classification Criteria ≥3 month disease duration . Moderately severely active RA define : At least 4 68 tender joint 4 66 swollen joint screen visit . High sensitivity CReactive Protein ( hsCRP ) ≥4mg/L Erythrocyte sedimentation rate ( ESR ) ≥28 mm/hr screen visit . For combination stratum : Patients continuous treatment nonbiologic DMARDs MTX least 12 week prior randomization . OR Patients per investigator judgment inappropriate , intolerant inadequate MTX treatment . Exclusion criterion : Patients &lt; 20 year age . Prior treatment tumor necrosis factor ( TNF ) antagonists RAdirected biologic agent without appropriate offdrug period prior screen . Prior treatment antiinterleukin6 ( antiIL6 ) antiinterleukin6 receptor ( IL6R ) antagonist therapy , include limited tocilizumab sarilumab . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>